STK11 Mutation Identified in Thyroid Carcinoma.

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Peutz-Jeghers syndrome (PJS) is an autosomal-dominant disorder linked to germline mutations in the serine threonine-protein kinase 11 (STK11) gene.
• STK11 mutations are found in up to 90% of patients meeting PJS clinical criteria.

Observation:

• Two elderly patients with thyroid carcinoma were analyzed.
• Case 1: A 71-year-old male with high-grade follicular thyroid carcinoma showed TP53 and STK11 mutations.
• Case 2: A 76-year-old female with tall cell variant papillary thyroid carcinoma exhibited BRAF and STK11 mutations.

Findings:

• Both patients had thyroid carcinomas with STK11 mutations.
• Neither patient presented with the characteristic clinical manifestations of Peutz-Jeghers syndrome.
• Genomic DNA analysis revealed specific mutations in STK11, including an intronic deletion and a missense mutation.

Implications:

• The study suggests a potential role for STK11 mutations in the development of thyroid carcinoma.
• These findings expand the known spectrum of diseases associated with STK11 alterations.
• Further research is warranted to elucidate the precise mechanisms by which STK11 mutations contribute to thyroid tumorigenesis.